These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 27534788

  • 1. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
    Sýkorová A, Pytlík R, Móciková H, Belada D, Benešová K, Papajík T, Janíková A, Šálek D, Procházka V, Vokurka S, Campr V, Klener P, Kubáčková K, Trněný M.
    Klin Onkol; 2016; 29(4):295-302. PubMed ID: 27534788
    [Abstract] [Full Text] [Related]

  • 2. Staging and response assessment in lymphomas: the new Lugano classification.
    Cheson BD.
    Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
    [Abstract] [Full Text] [Related]

  • 3. Revised staging system for malignant lymphoma based on the Lugano classification.
    Munakata W, Terauchi T, Maruyama D, Nagai H.
    Jpn J Clin Oncol; 2019 Oct 01; 49(10):895-900. PubMed ID: 31504700
    [Abstract] [Full Text] [Related]

  • 4. PET/CT for Staging; Past, Present, and Future.
    El-Galaly TC, Gormsen LC, Hutchings M.
    Semin Nucl Med; 2018 Jan 01; 48(1):4-16. PubMed ID: 29195617
    [Abstract] [Full Text] [Related]

  • 5. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
    Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cheson BD.
    J Clin Oncol; 2014 Sep 20; 32(27):3048-58. PubMed ID: 25113771
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group].
    Móciková H, Marková J, Gahérová Ľ, Král Z, Sýkorová A, Belada D, Procházka V, Martinková L, Papajík T, Kozák T.
    Klin Onkol; 2016 Sep 20; 29(5):342-346. PubMed ID: 27739312
    [Abstract] [Full Text] [Related]

  • 7. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).
    Ricard F, Barrington S, Korn R, Brueggenwerth G, Trotman J, Cheson B, Salles G, Schwartz L, Goldmacher G, Jarecha R, Narang J, Broussais F, Galette P, Liu M, Bajpai S, Perlman E, Gillis J, Smalberg I, Terve P, Zahlmann G, Schmid A.
    J Nucl Med; 2023 Feb 20; 64(2):239-243. PubMed ID: 35835581
    [Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET/CT in the clinical management of patients with lymphoma.
    Tamayo P, Martín A, Díaz L, Cabrero M, García R, García-Talavera P, Caballero D.
    Rev Esp Med Nucl Imagen Mol; 2017 Feb 20; 36(5):312-321. PubMed ID: 28483374
    [Abstract] [Full Text] [Related]

  • 9. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical).
    Ricard F, Cheson B, Barrington S, Trotman J, Schmid A, Brueggenwerth G, Salles G, Schwartz L, Goldmacher G, Jarecha R, Narang J, Broussais F, Galette P, Liu M, Bajpai S, Perlman E, Gillis J, Smalberg I, Terve P, Zahlmann G, Korn R.
    J Nucl Med; 2023 Jan 20; 64(1):102-108. PubMed ID: 35835580
    [Abstract] [Full Text] [Related]

  • 10. PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
    Karls S, Shah H, Jacene H.
    Semin Nucl Med; 2018 Jan 20; 48(1):37-49. PubMed ID: 29195616
    [Abstract] [Full Text] [Related]

  • 11. Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic.
    Miloš P, Jana S, Vítězslav K, Monika Š, Leona K, Jaromír R, Renata C, Markéta Č, Andrea B, Juraj K, Michal H, Milada Z, Marek K, Helena Č, Martin S.
    Klin Onkol; 2018 Jan 20; 31(3):207-212. PubMed ID: 30441974
    [Abstract] [Full Text] [Related]

  • 12. [Current Progresses in Developing PET Radiopharmaceuticals for Patients in the Czech Republic].
    Adam J, Demlová R, Řehák Z.
    Klin Onkol; 2016 Jan 20; 29 Suppl 4():S95-100. PubMed ID: 27846727
    [Abstract] [Full Text] [Related]

  • 13. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.
    Meignan M, Barrington S, Itti E, Gallamini A, Haioun C, Polliack A.
    Leuk Lymphoma; 2014 Jan 20; 55(1):31-7. PubMed ID: 23763460
    [Abstract] [Full Text] [Related]

  • 14. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L.
    Semin Radiat Oncol; 2007 Jul 20; 17(3):190-7. PubMed ID: 17591566
    [Abstract] [Full Text] [Related]

  • 15. Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT.
    Yoo KH.
    Blood Res; 2022 Apr 30; 57(S1):75-78. PubMed ID: 35483930
    [Abstract] [Full Text] [Related]

  • 16. [Update on the use of FDG-PET/CT in malignant lymphoma].
    Terauchi T.
    Rinsho Ketsueki; 2016 Apr 30; 57(10):2008-2012. PubMed ID: 27795508
    [Abstract] [Full Text] [Related]

  • 17. Imaging for Staging and Response Assessment in Lymphoma.
    Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J.
    Radiology; 2015 Aug 30; 276(2):323-38. PubMed ID: 26203705
    [Abstract] [Full Text] [Related]

  • 18. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
    Fayette D, Gahérová Ľ, Móciková H, Marková J, Kozák T, Horáček J.
    Klin Onkol; 2017 Aug 30; 30(2):93-99. PubMed ID: 28397504
    [Abstract] [Full Text] [Related]

  • 19. Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic.
    Linda Č, Markéta K, Ivana T, Eva P, Milada M, Hana V, Ondřej H, Karolína B, Jiří D, Monika B, Pavel D.
    Klin Onkol; 2018 Aug 30; 31(5):353-360. PubMed ID: 30541321
    [Abstract] [Full Text] [Related]

  • 20. ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
    Ladetto M, Buske C, Hutchings M, Dreyling M, Gaidano G, Le Gouill S, Luminari S, Pott C, Zamò A, Zucca E, ESMO Lymphoma Consensus Conference Panel Members.
    Ann Oncol; 2016 Dec 30; 27(12):2149-2160. PubMed ID: 27701070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.